Science
Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases – Phys.org
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle…
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.
The results suggest that someday, a handful of well-targeted drugs might be able to treat the more than 40 human disordersincluding Huntington’s disease and variants of amyotrophic lateral sclerosis (ALS)that arise from RNA-repeat expansions.
“This study lays a foundation for the development…
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business17 hours agoDicker Data rides the AI trend to double digit growth
-
Business20 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy